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ABSTRACT
Background:  Prediction  of  esophageal  varices  in  cirrhotic  patients  by  noninvasive 
methods is still unsatisfactory.
Objectives: To evaluate the accuracy of an artificial neural network (ANN) in predicting 
varices in patients with HBV related cirrhosis.
Patients and Methods: An ANN was constructed with data taken from 197 patients with 
HBV related cirrhosis. The candidates for input nodes of the ANN were assessed by uni-
variate analysis and sensitivity analysis. Five-fold cross validation was performed to 
avoid over-fitting.
Results: 14 variables were reduced by univariate and sensitivity analysis, and an ANN 
was developed with three variables (platelet count, spleen width and portal vein di-
ameter). With a cutoff value of 0.5. The ANN model has a sensitivity of 96.5%, specificity 
of 60.4%, positive predictive value of 86.9%, negative predictive value of 86.5% and a 
diagnostic accuracy of 86.8% for the prediction of varices.
Conclusions: An ANN may be useful for predicting presence of esophageal varices in 
patients with HBV related cirrhosis.
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1. Background
Despite significant improvements in the early diagnosis 
and  treatment  of  esophageal  variceal  bleeding,  the 
mortality rate of the first episode of variceal bleeding 
still  remains  high  (1).  Early  identification  of  patients 
with esophageal varices (EV) may be helpful for primary 
prophylaxis.  Though  the  upper  gastrointestinal 
endoscopy remains the gold standard for the diagnosis 
of  gastroesophageal  varices,  non  invasive  diagnostic 
means are desired to reduce the frequency of endoscopic 
examinations and related costs. A number of studies have 
addressed the issue and identified a series of predictors 
such  as  platelet  count  (2),  spleen  width,  portal  vein 
diameter (1-3), and platelet count/bipolar spleen diameter 
ratio (4). However, different studies performed in cirrhotic 
patients have yielded different results (5). Such predictive 
factors may be expected to vary in different populations 
because of differences in the etiologies of liver cirrhosis 
and  severity  of  liver  disease.  It  has  been  known  that 
cirrhotic patients in China, Southeast Asia usually have 
a higher proportion with HBV etiology (1). A recent study 
has  demonstrated  that  an  artificial  neural  network Hepat Mon. 2011;11(7):544-547
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(ANN) analysis is potentially more successful than the 
conventional statistical techniques in predicting clinical 
outcomes when the relationship between variables that 
determine the prognosis is complex, multidimensional 
and non-linear (6).
2. Objectives
The aim of this study was to evaluate the accuracy of 
an ANN in predicting EV in patients with HBV related 
cirrhosis.
3. Patients and Methods
197 patients with HBV-related cirrhosis were enrolled in 
this study between July 2005 and August 2008. Exclusion 
criteria have been previously described in detail (1). Age, 
gender  and  biochemical  parameters  were  recorded. 
Spleen width and portal vein diameter were measured by 
ultrasonography (7). The presence and degree of ascites 
and  encephalopathy  was  assessed  according  to  Child-
Pugh criteria (8). All gastrointestinal endoscopies were 
performed  by  several  senior  endoscopists  (WDH,  QHZ 
and others). All endoscopic results were re-evaluated by 
two  endoscopists  (WDH  and  QHZ)  who  were  unaware 
of  the  patients’  clinical  and  ultrasonographic  results. 
Any disagreements on the size of EV were resolved by 
discussion.  Kappa  statistic  was  used  to  measure  the 
level  of  inter-observer  agreement  for  the  size  of  EV 
was 0.80. The size of varices was subdivided into two 
classes: “small” and “large” (9). Diuretics therapy was not 
commenced before endoscopy and ultrasonography. The 
study protocol was approved by the Ethic Committee of 
the First Affiliated Hospital of Wenzhou Medical College. 
A Shapiro Wilk test was used to evaluate if the continuous 
data  had  normal  distribution.  Normally  distributed 
variables were presented as mean ± SD and compared 
with Student’s t test. Non normally distributed variables 
were  presented  as  median  and  interquartile  range 
and  compared  by  Mann-Whitney  U  test.  Categorical 
values  were  compared  by  x  ²  test.  Variables  found  to 
be  significantly  correlated  to  the  presence  of  EV  were 
selected as candidates for inputs of the ultimate ANN 
model. Sensitivity analysis (also known as independent 
variable  importance  analysis)  was  also  performed  by 
SPSS 16.0 software to determine the optimum variables 
which  would  be  used  to  construct  the  ultimate  ANN 
model (10). When performing sensitivity analysis, data 
were randomly divided into a training sample (n = 110, 
56%), testing sample (n = 30, 15%) and holdout sample (n 
= 57, 29%).
An exploratory, three-layered, multiplayer perceptron 
ANN  model,  with  back  propagation  algorithm  was 
constructed  for  sensitivity  analysis.  Sigmoid  transfer 
functions were used in the hidden and output layers. 
Gradient  descent  was  used  to  estimate  the  synaptic 
weights. The learning rate was 0.1 and the momentum 
was 0.1 (11). According to the results of univariate and 
sensitivity  analyses,  for  all  studied  197  patients,  an 
ultimate,  three-layered,  feed-forward  ANN  model  with 
three hidden nodes, with back propagation algorithm 
Variables Patients without EV (n = 53) Patients with EV (n = 144) P value
Age, y, Mean ± SD 55.3 ± 13.3 52.8 ± 11.5 0.20 b
Male, % 66.0 65.9 0.99 a
Total bilirubin, μmol/L 23 (15–40) 29.5 (21–43.5)  0.21 c
Albumin, g/L 34 (26–38.7) 31 (27.5–35.7) 0.23 c
ALT, U/L 37 (31–61) 43.5 (29.5–66) 0.69 c
AST, U/L 58 (35–85) 64 (41–84) 0.38 c 
Alkaline phosphatase, U/L 99 (70–123) 101 (72–131) 0.63 c
γ-GT, U/L 55 (33–93) 60.5 (36.5–112.5) 0.43 c
Prothrombin time, s 16.5 (15.3–18.9) 17.5 (15.6–19.8) 0.19 c
Prothrombin activity, % 64 (54–76) 60.5 (50–70.5) 0.15 c
Platelets, 10 9/L 75 (56–109) 49 (32–66) < 0.001 c
Ascites, No. 0.03 a
None
Non-tense
Tense
44
6
3
93
25
26
Portal vein diameter, mm 11 (10–12) 13 (12–14) < 0.001 c
Spleen width, mm 40 (38–44) 51 (44–60) < 0.001 c
Table 1. Univariate analysis of predictors of esophageal varices in 197 patients
a Student's t-test
b X2 test 
c Mann-Whitney U-testHepat Mon. 2011;11(7):544-547
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was constructed by JMP 6.0 software.
Generally speaking, neural network models are highly 
over-parameterized, so that models that seem to offer the 
best fit of the (training) data are over-fit for other data. 
To prevent over-fitting in large data sets, it is suggested 
that  the  data  should  be  partitioned  into  a  “training 
group” used for fitting the model and a “testing group” 
for  comparing  models  that  have  been  fitted  to  the 
training data (12). However, for a small dataset a k-fold 
cross-validation model is more suitable and reliable to 
prevent over-training (12, 13). So, in the present study, we 
performed five-fold cross-validation in all 197 patients. 
The ANN model was trained with maximum iterations of 
500 and 10 tours. The over-fit penalty was set to 0.001; the 
convergence criterion was set to 0.00001. The output of 
ANN model was transformed to range (0–1). Presence of 
EV was predicted if the output was greater than or equal 
to 0.5 (12). The sensitivity, specificity, negative predictive 
value, positive predictive value and diagnostic accuracy 
of  the  ANN  model  were  reported.  Differences  were 
considered to be statistically significant if the two-tailed 
p value was less than 0.05.
4. Results
Of 197 studied patients, 130 (66%) were male; the patients 
had a mean ± SD age of 53.5 ± 12 years. The prevalence 
of EV was 73.1%. The majority of the patients had Child-
Pugh class A (39.1%) and B (41.1%). Ascites was found in 
30.5%  of  the  patients  by  ultrasonography  and  clinical 
examination.
4.1. Artificial neural network analysis
Fourteen variables considered relevant to the presence 
of EV were tested using univariate analysis (Table 1). Four 
variables (platelet count, ascites, spleen width and portal 
vein  diameter)  were  significantly  associated  with  the 
presence  of  EV,  of  which  platelet  count,  spleen  width 
and portal vein diameter were also noted as the most 
important predictors of EV by sensitivity analysis (Figure 
1)  (The  exploratory  ANN  model  constructed  by  SPSS 
16.0 for sensitivity analysis is not shown). Therefore, an 
ultimate three-layer 3-3-1 feed-forward back-propagation 
ANN  model,  which  was  consisted  of  platelet  count, 
spleen width and portal vein diameter, was developed 
and trained by JMP 6.0 software in 197 patients (Figure 
2).  Sensitivity,  specificity,  positive  predictive  value, 
negative  predictive  value  and  diagnostic  accuracy  of 
ANN in comparison with endoscopy examination in the 
diagnosis of EV in patients with HBV related cirrhosis are 
shown in Table 2.
5. Discussion
Data on the relationship between thrombocytopenia 
and  the  risk  of  EV  is  somewhat  conflicting.  Several 
studies  suggest  that  platelet  count  may  predict 
the  presence  of  EV  in  patients  with  cirrhosis  (2,  14). 
However,  recent  data  obtained  by  logistic  regression 
analysis  do  not  support  any  correlation  between 
thrombocytopenia and varices (1, 5). Our data by ANN 
analysis showed that thrombocytopenia was one of the 
independent  risk  factors  for  the  presence  of  EV.  This 
may in part be attributed to the fact that ANN analysis 
is  potentially  more  successful  than  conventional 
statistical  techniques  in  predicting  clinical  outcomes 
when the relationship between predictors and outcomes 
is complex and nonlinear. This is evidenced by the fact 
that thrombocytopenia in cirrhotic patients is not only 
attributed to hypersplenism due to portal hypertension 
Table 2. Artificial neural network performance in predicting the presence of 
esophageal varices
EV b No EV b Total
ANN result a
Positive
Negative
135
9
15
38
150
47
Total 144 53 197
a ANN: Artificial neural network; Sensitivity: 93.75%; Specificity: 71.70%; Positive 
predictive value: 90.00%; Negative predictive value: 80.85%; Diagnostic accur-
acy: 87.82%
b EV: Esophageal varices
Figure 2. Schematic diagram of the ANN model developed to predict the 
presence of EV
Varices
H1
H2
H3
Portal vein diameter
Platelets
Spleen width
Input layer                    Hidden layer           Output layer
The value shown for each input variable is a measure of its relative import-
ance.
Figure 1. Sensitivity analysis of input variables.Hepat Mon. 2011;11(7):544-547
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but also resulted from decreased thrombopoeitin and 
interleukin-11 (1). Splenomegaly is a common finding in 
cirrhotic patients with portal hypertension. Lamb et al. 
found that there was a good correlation between in vivo 
ultrasound assessment of splenic width and true splenic 
volume (7). The present study showed that spleen width 
was  an  independent  predictor  for  the  presence  of  EV, 
which is also consistent with our previous observations 
(1, 3). Contrary to what was suggested in previous reports, 
no  significant  correlation  between  splenomegaly  and 
presence of EV was found in other studies (2, 15). These 
differences may be due to the variations among studies 
regarding the etiology and the stage of liver cirrhosis 
they studied. EV is the direct consequence of spontaneous 
formation of collateral vessels between portal vein and 
esophageal veins via left gastric or short gastric veins. 
Therefore, the presence or absence of EV may reflect the 
severity of portal hypertension. The results of the present 
study  indicate  that  the  portal  vein  diameter  could  be 
a valuable predictor of EV in patients with HBV related 
cirrhosis.  This  finding  was  consistent  with  previous 
reports (1, 3). As shown in Table 2, the ANN model, which 
was consisted of platelet count, spleen width and portal 
vein  diameter,  achieved  a  positive  predictive  value  of 
90.0%  and  a  negative  predictive  value  of  80.85%.  This 
means that if the ANN value is more than or equal to 
0.5, there is a probability of 90.0% for presence of EV. 
And, if ANN value is less than 0.5, there is a probability of 
80.85% for absence of EV. Overall, 87.82% of patients were 
correctly classified.
Our study has several limitations. Data were collected 
retrospectively, which might produce a population bias. 
In addition, the sample size was small and the grade of 
esophageal varices in studied patients was not compared. 
At last, although we preformed 5-fold cross validation 
and filtered out irrelevant input variables by univariate 
and sensitivity analysis to avoid over-fitting, testing the 
performance of ANN model with an independent sample 
set would be necessary in the future. In conclusion, an 
ANN  model,  which  was  consisted  of  platelet  count, 
spleen width and portal vein diameter, may be useful for 
predicting presence of EV in patients with HBV related 
cirrhosis.
Financial support
None declared.
Conflicts of interest
None declared.
References
1.  Hong WD, Zhu QH, Huang ZM, Chen XR, Jiang ZC, Xu SH, et al. 
Predictors of esophageal varices in patients with HBV-related 
cirrhosis: a retrospective study. BMC Gastroenterol. 2009;9:11.
2.  Burton JR, Jr., Liangpunsakul S, Lapidus J, Giannini E, Chalasani 
N,  Zaman  A.  Validation  of  a  multivariate  model  predicting 
presence and size of varices. J Clin Gastroenterol. 2007;41(6):609-
15.
3.  Hong WD, Dong LM, Jiang ZC, Zhu QH, Jin SQ. Prediction of large 
esophageal varices in cirrhotic patients using classification and 
regression tree analysis. Clinics (Sao Paulo). 2011;66(1):119-24.
4.  Abu El Makarem MA, Shatat ME, Shaker Y , Abdel Aleem AA, El 
Sherif AM, Abdel Moaty M, et al. Platelet count/bipolar spleen 
diameter  ratio  for  the  prediction  of  esophageal  varices:  The 
special Egyptian situation. Hepat Mon. 2011;11(4):278-84.
5.  Qamar  AA,  Grace  ND,  Groszmann  RJ,  Garcia-Tsao  G,  Bosch  J, 
Burroughs  AK,  et  al.  Platelet  count  is  not  a  predictor  of  the 
presence  or  development  of  gastroesophageal  varices  in 
cirrhosis. Hepatology. 2008;47(1):153-9.
6.  Vahdani P, Alavian SM, Aminzadeh Z, Raoufy MR, Gharibzadeh 
S, Vahdani G, et al. Using Artificial Neural Network to Predict 
Cirrhosis in Patients with Chronic Hepatitis B Infection with 
Seven Routine Laboratory Findings. Hepat Mon. 2009;9(4):271-5.
7.  Lamb PM, Lund A, Kanagasabay RR, Martin A, Webb JA, Reznek 
RH. Spleen size: how well do linear ultrasound measurements 
correlate with three-dimensional CT volume assessments? Br J 
Radiol. 2002;75(895):573-7.
8.  Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. 
Transection of the oesophagus for bleeding oesophageal varices. 
Br J Surg. 1973;60(8):646-9.
9.  de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson 
M,  Fleig  W,  et  al.  Definitions,  methodology  and  therapeutic 
strategies  in  portal  hypertension.  A  Consensus  Development 
Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J 
Hepatol. 1992;15(1-2):256-61.
10.  Piscaglia  F,  Cucchetti  A,  Benlloch  S,  Vivarelli  M,  Berenguer  J, 
Bolondi L, et al. Prediction of significant fibrosis in hepatitis 
C virus infected liver transplant recipients by artificial neural 
network analysis of clinical factors. Eur J Gastroenterol Hepatol. 
2006;18(12):1255-61.
11.  Mofidi  R,  Duff  MD,  Madhavan  KK,  Garden  OJ,  Parks  RW. 
Identification  of  severe  acute  pancreatitis  using  an  artificial 
neural network. Surgery. 2007;141(1):59-66.
12.  Sall  J,  Creighton  L,  Lehman  A.  JMP  Start  Statistics:  A  Guide  to 
Statistics and Data Analysis Using Jmp. Fourth ed. Cary, NC: SAS 
Institute; 2007.
13.  Bektas  F,  Eken  C,  Soyuncu  S,  Kilicaslan  I,  Cete  Y.  Artificial 
neural  network  in  predicting  craniocervical  junction  injury: 
an alternative approach to trauma patients. Eur J Emerg Med. 
2008;15(6):318-23.
14.  Madhotra  R,  Mulcahy  HE,  Willner  I,  Reuben  A.  Prediction  of 
esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 
2002;34(1):81-5.
15.  Schepis  F,  Camma  C,  Niceforo  D,  Magnano  A,  Pallio  S, 
Cinquegrani  M,  et  al.  Which  patients  with  cirrhosis  should 
undergo endoscopic screening for esophageal varices detection? 
Hepatology. 2001;33(2):333-8.
 